[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100532991":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":25,"centralContacts":25,"locations":26,"responsibleParty":52,"collaborators":25,"id":56,"slug":57,"hasResults":58,"nctId":59,"briefTitle":60,"officialTitle":60,"acronym":61,"eligibilityCriteria":62,"healthyVolunteers":58,"sex":63,"minAge":64,"maxAge":25,"enrollmentInfo":65,"targetDuration":25,"studyType":68,"phases":69,"briefSummary":71,"conditions":72,"keywords":74,"overallStatus":29,"whyStopped":25,"lastUpdateSubmitDate":81,"lastUpdatePostDateStruct":82,"startDateStruct":85,"completionDateStruct":87,"leadSponsor":89,"locationsCount":90},{"fullName":5,"class":6},"Hospital Clinic of Barcelona","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Pulsed Field Ablation","EXPERIMENTAL","Pulmonary vein isolation using the Farapulse Pulsed Field Ablation System (Boston Scientific)",[13],"Procedure: Pulmonary vein isolation",{"label":15,"type":16,"description":17,"interventionNames":18},"Cryoballoon Ablation","ACTIVE_COMPARATOR","Pulmonary vein isolation using the Medtronic Cryoballoon Ablation System",[13],[20],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"PROCEDURE","Pulmonary vein isolation","Catheter ablation",[15,9],null,[27],{"facility":28,"status":29,"city":30,"state":31,"zip":32,"country":33,"countryCode":34,"cosmosGeoPoint":35,"geoPoint":40,"contacts":41},"Hospital Clinic, University of Barcelona","RECRUITING","Barcelona","Catalonia","08036","Spain","ES",{"type":36,"coordinates":37},"Point",[38,39],2.15899,41.38879,{"lat":39,"lon":38},[42,47,50],{"name":43,"role":44,"phone":45,"phoneExt":25,"email":46},"Ivo Roca-Luque, M.D.","CONTACT","+34932275551","iroca@clinic.cat",{"name":48,"role":49,"phone":25,"phoneExt":25,"email":25},"Lluis Mont, M.D.","SUB_INVESTIGATOR",{"name":51,"role":49,"phone":25,"phoneExt":25,"email":25},"Till F Althoff, M.D.",{"type":53,"investigatorFullName":54,"investigatorTitle":55,"investigatorAffiliation":5,"oldNameTitle":25,"oldOrganization":25},"PRINCIPAL_INVESTIGATOR","Ivo Roca","Head of Arrhythmia Section. Professor of Cardiology","100532991","lesion-formation-with-pulsed-field-versus-cryobaloon-ablation-as-assessed-by-cardiac-magnetic-resoncance-100532991",false,"NCT06220006","Lesion Formation With Pulsed Field Versus Cryobaloon Ablation as Assessed by Cardiac Magnetic Resoncance","PULSED-ICE-CMR","Inclusion Criteria:\n\n* Patients scheduled for first-time atrial fibrillation catheter ablation\n\nExclusion Criteria:\n\n* age \\\u003C18 years\n* long-standing persistent atrial fibrillation\n* prior left atrial ablation\n* pregnancy or lactation\n* reduced left ventricular ejection fraction\n* GFR \\\u003C30%\n* BMI \\>35%\n* left atrial diameter \\>55 mm\n* cardiac implantable electronic device","ALL","18 Years",{"count":66,"type":67},104,"ESTIMATED","INTERVENTIONAL",[70],"NA","This randomised study will compare pulsed field ablation and cryoballoon ablation with respect to ablation lesion quality as assessed by late gadolinium enhancement (LGE) cardiac magnetic resonance (CMR) at 3 months post-ablation. Patients scheduled for first-time AF ablation will be randomised in a 2:1 fashion to receive PVI-only, either by pulsed field ablation (Farapulse Pulsed Field Ablation System, Boston Scientific) or cryoballoon ablation (Medtronic Cryoballoon Ablation System).",[73],"Atrial Fibrillation",[75,23,76,22,77,78,79,80],"Atrial fibrillation","Ablation lesion","Pulsed field ablation","Cryoballoon ablation","Cardiac magnetic resonance","Late gadolinium enhancement","2026-04-01",{"date":83,"type":84},"2026-04-07","ACTUAL",{"date":86,"type":84},"2023-11-01",{"date":88,"type":67},"2026-11-01",{"name":5,"class":6},1]